Calithera Biosciences (Nasdaq:CALA), a clinical stage biotechnology ... 2016 San Antonio Breast Cancer Symposium, December 6-10, 2016 in San ...
News
- Calithera Biosciences Reports CB-839 Phase I Triple Negative Breast Cancer Combination Data at ...
- City Welcomes Princess Astrid of Belgium to San Antonio
... before leading the princess into the building for a focus session on San Antonio's cybersecurity, advanced research, and biomedical and health care ...
- Royalty from Belgium visit the Alamo City
SAN ANTONIO - On Tuesday, royalty enjoyed the River Walk as the ... the delegates learned how San Antonio is a city with a vibrant biomedical and ...
- Biotech Stocks Worth a Closer Look: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Spectrum ...
Biotech Stocks Worth a Closer Look: BioMarin Pharmaceutical Inc. ... at the San Antonio Breast Cancer Symposium (SABCS), being held in San Antonio, ... Spectrum Pharmaceuticals is a leading biotechnology company focused on ...
- Calithera Biosciences Reports CB-839 Phase I Triple Negative Breast Cancer Combination Data at ...
... a first-in-class glutaminase inhibitor, will be presented at the 2016 San Antonio Breast Cancer Symposium, December 6-10, 2016 in San Antonio, ...